When Tyler James Hadley was born, his parents thought they had brought home a perfectly healthy baby boy. He weighed a healthy 7lb 8oz, arrived via emergency caesarean after a difficult labour, and despite needing brief resuscitation at birth, he was soon in his parents’ arms. For Louis Hadley and Lisa Money, those first days felt full of relief, love, and cautious excitement — the beginning of a life they assumed would unfold like any other child’s.
In the early weeks, Tyler seemed content. He fed, slept, and gazed up at his parents with wide eyes. One small habit stood out, though — he often poked his tongue in and out. Louis and Lisa found it endearing, a quirky little trait that made them smile. They had no idea it was one of the earliest warning signs of a rare and deadly condition.
As the months passed, subtle differences began to emerge.
Tyler wasn’t rolling over. He wasn’t sitting up. While friends’ babies of a similar age started to wriggle, kick, and explore, Tyler remained unusually floppy. Still, nothing prepared his parents for what they would eventually learn.
“It never crossed our minds that something serious was wrong,” Louis said. “We thought he was just developing at his own pace.”
Everything changed when Tyler was five months old.
One afternoon, while being given Calpol, Tyler suddenly began choking. He struggled to swallow, his body limp and unresponsive. Terrified, Louis and Lisa rushed him to hospital. This time, doctors noticed what others had missed. Tyler’s muscle tone was extremely weak. He wasn’t just choking — he was unable to control the muscles needed to swallow.
Tests followed quickly. The results shattered his parents’ world.
Tyler was diagnosed with spinal muscular atrophy (SMA) type 1 — the most severe form of a rare genetic neuromuscular disease. Doctors explained that most babies with this diagnosis do not live beyond their second birthday.
“We had never even heard of SMA,” Louis said. “When they told us most children don’t make it to two, we just broke down. You never think you’re going to hear that about your own child.”
Spinal muscular atrophy is caused by a fault in the SMN1 gene, which produces a protein essential for motor neurons — the nerve cells that allow the brain and spinal cord to communicate with muscles. Without enough of this protein, the motor neurons deteriorate, causing muscles to weaken and waste away. In SMA type 1, the disease progresses rapidly, affecting movement, breathing, and swallowing.
Looking back, Tyler’s early signs suddenly made sense.
The flickering tongue.
The floppiness.
The missed milestones.
“What we thought was cute was actually his body struggling,” Louis said quietly.
For Louis and Lisa, the diagnosis felt cruelly ironic. Tyler looked bright-eyed and alert. He smiled. He responded to their voices. But inside, his muscles were weakening day by day.
Doctors explained that there was no cure — but there was hope.
A relatively new drug called Spinraza had shown promise in slowing or stopping the progression of SMA by helping the body produce more of the missing protein. In the UK, however, access to the drug was limited, with clinical trials and long waiting lists. Time was something Tyler did not have.
Refusing to wait, Louis and Lisa searched for alternatives.
They learned that Spinraza was available privately in Europe, including at Hôpital Bicêtre in Paris. The treatment involved repeated injections directly into the spine — an invasive process, but one that offered a chance to preserve Tyler’s strength and extend his life.
“We don’t know if it will help,” Louis said. “But we’re willing to try anything. Doing nothing isn’t an option.”
Friends and family rallied around them, launching a GoFundMe campaign to help cover the enormous costs — treatment, travel, accommodation, and specialist equipment Tyler may need as his condition progresses. The fundraising goal was set at £50,000, not as a guarantee, but as a lifeline.
In March, after raising several thousand pounds, the family travelled to France. Tyler received his first spinal injection — a moment filled with fear, hope, and quiet determination. More treatments are scheduled in the weeks and months ahead, followed by injections every four months.
Now nine months old, Tyler continues to battle a disease that threatens to steal his strength, his independence, and his future. Yet he remains surrounded by love, fought for fiercely by parents who refuse to give up.
“Seeing him in hospital breaks your heart,” Lisa said. “But knowing there’s something out there that might help him gives us hope we didn’t have before.”
Tyler’s story is one of how easily devastating illnesses can hide behind seemingly harmless signs. A flickering tongue. A delayed milestone. A moment that looked cute — until it wasn’t.
For Louis and Lisa, every day with their son is precious.
They don’t know how long they have. They don’t know how far treatment will take them. But they know this: Tyler is more than his diagnosis. He is their son. And as long as there is even a small chance to help him, they will keep fighting.
Because sometimes, hope begins with noticing what others overlook — and choosing to act before it’s too late.
